Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial

OBJECTIVE: Hypoglycemia is a frequent and potentially dangerous event among patients with diabetes mellitus type 1. Subcutaneous glucagon is an emergency treatment to counteract severe hypoglycemia. The effect of intraperitoneal glucagon delivery is sparsely studied. We performed a direct comparison...

Descripción completa

Detalles Bibliográficos
Autores principales: Dirnena-Fusini, Ilze, Åm, Marte Kierulf, Fougner, Anders Lyngvi, Carlsen, Sven Magnus, Christiansen, Sverre Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235059/
https://www.ncbi.nlm.nih.gov/pubmed/30487972
http://dx.doi.org/10.1136/bmjdrc-2018-000560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235059/
https://www.ncbi.nlm.nih.gov/pubmed/30487972
http://dx.doi.org/10.1136/bmjdrc-2018-000560

Ejemplares similares